Wu Y - Search Results

1

Allosterically inhibited PFKL via prostaglandin E2 withholds glucose metabolism and ovarian cancer invasiveness.

Chen S, Wu Y, Gao Y, Wu C, Wang Y, Hou C, Ren M, Zhang S, Zhu Q, Zhang J, Yao Y, Huang M, Qi YB, Liu XS, Horng T, Wang H, Ye D, Zhu Z, Zhao S, Fan G. Chen S, et al. Among authors: wu y, wu c. Cell Rep. 2023 Oct 31;42(10):113246. doi: 10.1016/j.celrep.2023.113246. Epub 2023 Oct 12. Cell Rep. 2023. PMID: 37831605 Free article.

2

Crystal Structure of the Human Cannabinoid Receptor CB₁.

Hua T, Vemuri K, Pu M, Qu L, Han GW, Wu Y, Zhao S, Shui W, Li S, Korde A, Laprairie RB, Stahl EL, Ho JH, Zvonok N, Zhou H, Kufareva I, Wu B, Zhao Q, Hanson MA, Bohn LM, Makriyannis A, Stevens RC, Liu ZJ. Hua T, et al. Among authors: wu y, wu b. Cell. 2016 Oct 20;167(3):750-762.e14. doi: 10.1016/j.cell.2016.10.004. Cell. 2016. PMID: 27768894 Free PMC article.

3

Structural insights into the committed step of bacterial phospholipid biosynthesis.

Li Z, Tang Y, Wu Y, Zhao S, Bao J, Luo Y, Li D. Li Z, et al. Among authors: wu y. Nat Commun. 2017 Nov 22;8(1):1691. doi: 10.1038/s41467-017-01821-9. Nat Commun. 2017. PMID: 29167463 Free PMC article.

4

Salvianolic acids from antithrombotic Traditional Chinese Medicine Danshen are antagonists of human P2Y₁ and P2Y₁₂ receptors.

Liu X, Gao ZG, Wu Y, Stevens RC, Jacobson KA, Zhao S. Liu X, et al. Among authors: wu y. Sci Rep. 2018 May 24;8(1):8084. doi: 10.1038/s41598-018-26577-0. Sci Rep. 2018. PMID: 29795391 Free PMC article.

5

Author Correction: Salvianolic acids from antithrombotic Traditional Chinese Medicine Danshen are antagonists of human P2Y₁ and P2Y₁₂ receptors.

Liu X, Gao ZG, Wu Y, Stevens RC, Jacobson KA, Zhao S. Liu X, et al. Among authors: wu y. Sci Rep. 2018 Jul 24;8(1):11380. doi: 10.1038/s41598-018-29406-6. Sci Rep. 2018. PMID: 30038283 Free PMC article.

6

A structurally guided dissection-then-evolution strategy for ligand optimization of smoothened receptor.

Ye L, Ding K, Zhao F, Liu X, Wu Y, Liu Y, Xue D, Zhou F, Zhang X, Stevens RC, Xu F, Zhao S, Tao H. Ye L, et al. Among authors: wu y. Medchemcomm. 2017 Apr 28;8(6):1332-1336. doi: 10.1039/c7md00104e. eCollection 2017 Jun 1. Medchemcomm. 2017. PMID: 30108845 Free PMC article.

7

GPCR Allosteric Modulator Discovery.

Wu Y, Tong J, Ding K, Zhou Q, Zhao S. Wu Y, et al. Adv Exp Med Biol. 2019;1163:225-251. doi: 10.1007/978-981-13-8719-7_10. Adv Exp Med Biol. 2019. PMID: 31707706 Review.

8

Molecular Mechanism for Ligand Recognition and Subtype Selectivity of α_2C Adrenergic Receptor.

Chen X, Xu Y, Qu L, Wu L, Han GW, Guo Y, Wu Y, Zhou Q, Sun Q, Chu C, Yang J, Yang L, Wang Q, Yuan S, Wang L, Hu T, Tao H, Sun Y, Song Y, Hu L, Liu ZJ, Stevens RC, Zhao S, Wu D, Zhong G. Chen X, et al. Among authors: wu y, wu d, wu l. Cell Rep. 2019 Dec 3;29(10):2936-2943.e4. doi: 10.1016/j.celrep.2019.10.112. Cell Rep. 2019. PMID: 31801061 Free article.

9

Metabolic Reprogramming in Cancer Is Induced to Increase Proton Production.

Sun H, Zhou Y, Skaro MF, Wu Y, Qu Z, Mao F, Zhao S, Xu Y. Sun H, et al. Among authors: wu y. Cancer Res. 2020 Mar 1;80(5):1143-1155. doi: 10.1158/0008-5472.CAN-19-3392. Epub 2020 Jan 13. Cancer Res. 2020. PMID: 31932456

10

Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-G_i Complex Structures.

Hua T, Li X, Wu L, Iliopoulos-Tsoutsouvas C, Wang Y, Wu M, Shen L, Brust CA, Nikas SP, Song F, Song X, Yuan S, Sun Q, Wu Y, Jiang S, Grim TW, Benchama O, Stahl EL, Zvonok N, Zhao S, Bohn LM, Makriyannis A, Liu ZJ. Hua T, et al. Among authors: wu y, wu m, wu l. Cell. 2020 Feb 20;180(4):655-665.e18. doi: 10.1016/j.cell.2020.01.008. Epub 2020 Jan 30. Cell. 2020. PMID: 32004463 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

78,325 results

Search Page